Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
about
Potential Usefulness of Clopidogrel Pharmacogenetics in Cerebral Endovascular Procedures and Carotid Artery Stenting.Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?Diffuse Alveolar Hemorrhage in Patients Undergoing Neurointervention: A Case Report.Antiplatelet testing in neurointervention: we cannot ignore the signs.Delayed ipsilateral parenchymal hemorrhage following treatment of intracranial aneurysms with flow diverter.Platelet function inhibitors and platelet function testing in neurointerventional procedures.Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy.Optimal pediatric dosing of anti-platelet agents for pipeline stent embolization -a case report and review of the literature.Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy.Prospective Study of Early MRI Appearances following Flow-Diverting Stent Placement for Intracranial Aneurysms.Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications.Point of care platelet function testing in routine neurointerventional care is unjustified.Clinical and angiographic outcomes in patients with intracranial aneurysms treated with the pipeline embolization device: intra-procedural technical difficulties, major morbidity, and neurological mortality decrease significantly with increased operAccumetrics-based clopidogrel dosing in endovascular neurosurgery.Platelet function testing: does a randomized controlled trial settle the debate?Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device.Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation.Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis.Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneur
P2860
Q33818356-64F817EE-862F-4CB7-853E-28A1296C4C12Q35905832-F72D4AD0-3F98-4355-B70F-EF67CAEB1C93Q37401274-FA13ADE1-EA17-4A9F-9819-1A39A860917BQ38114045-FFB99A24-2298-41A4-BAA6-8A3D9C842642Q38163327-0B59EAD5-F072-4A45-BCAF-970B8A52EFC3Q38233284-A51A797F-5838-4C01-9E37-17061C2FCC77Q38971852-9B454E6B-A0C6-4964-AFAA-C6879AB41895Q39037199-D9A09F49-0A81-4D65-A25A-D111CBD767D9Q39208503-F026D5FA-E91C-43DC-B67D-C92F4A80E293Q40575125-681EA5C6-A46A-46DB-9056-3E81B93FB11BQ41231648-9100EBA8-6B66-4533-949C-77CD4101B52CQ41574497-DD6729D7-A1BC-4DC9-8575-6E1EF5B43200Q45912513-5840D144-D18F-4B4C-B506-6510BDDB4BCAQ47593505-75C2D452-ECF8-47F9-A341-749B978FB97FQ48013353-8083F9A4-BB9E-40E7-8F27-BE7E50BF8D95Q48154693-94D6E60F-CE35-4226-82E3-F84A14215C2DQ48964241-5F33DCAA-2A79-4F50-830C-5AC662FEF206Q50857320-184241BA-6893-4972-A02D-75A66C2E4E2FQ50883518-5DBEB1AC-4609-4818-AECE-A4854F66C0D8Q53118529-5EFE1C32-0757-47F7-9028-15C2E679D5B5Q53577445-C9767A2A-BBD5-4632-B1C3-41593686BC29Q53765716-014A67BC-AD66-4205-ACA4-54816E58C8E0Q54419291-DFDAEEA1-A979-446D-884A-8B23AD42AA9C
P2860
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
@en
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
@nl
type
label
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
@en
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
@nl
prefLabel
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
@en
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
@nl
P2093
P2860
P356
P1476
Clopidogrel hyper-response and bleeding risk in neurointerventional procedures.
@en
P2093
P2860
P304
P356
10.3174/AJNR.A3418
P50
P577
2012-12-28T00:00:00Z